Evaluation of severe neutropenia and diarrhea in Asian cancer patients receiving UGT1A1 genotype-guided irinotecan dosing.

被引：0
|
作者：
Sutiman, Natalia
Ramasamy, Saminathan
Ng, Chau Hsien Matthew
Choo, SuPin
Wenrui, Rachel Lim
Ling, Clarinda Chua Wei
Kuang, John Chia Whay
Tan, Iain B.
Chowbay, Balram
机构：
[1] SingHlth Clin Pharmacol, Singapore, Singapore
[2] Natl Canc Ctr, Div Med Sci, Clin Pharmacol Lab, Singapore, Singapore
[3] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e13572
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13572
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Randomized Phase II Trial of Irinotecan with Paclitaxel or Gemcitabine for Non-small Cell Lung Cancer Association of UGT1A1*6 and UGT1A1*27 with Severe Neutropenia
    Nakamura, Yoichi
    Soda, Hiroshi
    Oka, Mikio
    Kinoshita, Akitoshi
    Fukuda, Minoru
    Fukuda, Masaaki
    Takatani, Hiroshi
    Nagashima, Seiji
    Soejima, Yoshifumi
    Kasai, Takashi
    Nakatomi, Katsumi
    Masuda, Noriyuki
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) : 121 - 127
  • [42] A Phase I Study of UGT1A1*28/*6 Genotype-Directed Dosing of Irinotecan (CPT-11) in Korean Patients with Metastatic Colorectal Cancer Receiving FOLFIRI
    Kim, Kyu-Pyo
    Hong, Yong Sang
    Lee, Jae-Lyun
    Bae, Kyun Seop
    Kim, Ho-Sook
    Shin, Jae-Gook
    Lee, Jung Shin
    Kim, Tae Won
    ONCOLOGY, 2015, 88 (03) : 164 - 172
  • [43] The UGT1A1*28 Genotype and the Toxicity of Low-Dose Irinotecan in Patients With Advanced Lung Cancer
    Sugiyama, Tomohide
    Hirose, Takashi
    Kusumoto, Sojiro
    Shirai, Takao
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Ohnishi, Tsukasa
    Ohmori, Tohru
    Adachi, Mitsuru
    ONCOLOGY RESEARCH, 2009, 18 (07) : 337 - 342
  • [44] DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan
    Falvella, Felicia Stefania
    Cheli, Stefania
    Martinetti, Antonia
    Mazzali, Cristina
    Iacovelli, Roberto
    Maggi, Claudia
    Gariboldi, Manuela
    Pierotti, Marco Alessandro
    Di Bartolomeo, Maria
    Sottotetti, Elisa
    Mennitto, Roberta
    Bossi, Ilaria
    de Braud, Filippo
    Clementi, Emilio
    Pietrantonio, Filippo
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (03) : 581 - 588
  • [45] Correlation of UGT1A1*28 and *6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients
    Atasilp, Chalirmporn
    Chansriwong, Pichai
    Sirachainan, Ekapob
    Reungwetwattana, Thanyanan
    Chamnanphon, Montri
    Puangpetch, Apichaya
    Wongwaisayawan, Sansanee
    Sukasem, Chonlaphat
    DRUG METABOLISM AND PHARMACOKINETICS, 2016, 31 (01) : 90 - 94
  • [46] ROLE OF UGT1A1*6 IN IRINOTECAN TOXICITY IN JAPANESE CANCER PATIENTS
    Kakihata, K.
    Sai, K.
    Mori, A.
    Saito, Y.
    Suzuki, T.
    Ando, Y.
    Hasegawa, Y.
    Sawada, J.
    Yoshida, T.
    ANNALS OF ONCOLOGY, 2008, 19 : 50 - 50
  • [47] UGT1A1 genotype as an indicator of neutropenia for FOLFOXIRI with bevacizumab in patients with mCRC (QUATTRO study)
    Oki, Eiji
    Yoshino, Takayuki
    Muro, Kei
    Emi, Yasunori
    Tsuji, Akihito
    Yamasaki, Kentaro
    Yamanaka, Takeharu
    Sakisaka, Hideki
    Kato, Takeshi
    Kanazawa, Akiyoshi
    ANNALS OF ONCOLOGY, 2016, 27
  • [48] UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study
    Kweekel, D. M.
    Gelderblom, H.
    Van der Straaten, T.
    Antonini, N. F.
    Punt, C. J. A.
    Guchelaar, H-J
    BRITISH JOURNAL OF CANCER, 2008, 99 (02) : 275 - 282
  • [49] UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study
    D M Kweekel
    H Gelderblom
    T Van der Straaten
    N F Antonini
    C J A Punt
    H-J Guchelaar
    British Journal of Cancer, 2008, 99 : 275 - 282
  • [50] Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype
    Roncato, R.
    Cecchin, E.
    Montico, M.
    De Mattia, E.
    Giodini, L.
    Buonadonna, A.
    Solfrini, V.
    Innocenti, F.
    Toffoli, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (01) : 123 - 130
12345